Skip to content
Research Article Open access CC BY 4.0

Exploration of Antioxidant, Antibacterial, and Alpha-glucosidase Inhibition Potential of Cirsium verutum (D. Don) Spreng Extracts: In vitro and in silico Approach

Manila Poudel, Nirmal Parajuli, Sabin Khanal, Bindira Gosain, Kanchan Shakhakarmi, Samjhana Bharati, Binita Maharjan, Timila Shrestha, Jhashanath Adhikari Subin, Ram Lal Swagat Shrestha, Bishnu Prasad Marasini

Asian Journal of Applied Chemistry Research · pp. 55–70 · Published 20 Jul 2024

10.9734/ajacr/2024/v15i4296

Abstract

Certain medicinal plants have been used to address common infectious as well as non-infectious diseases. Diabetes mellitus poses a major global health challenge, leading to significant mortality and morbidity each year. Finding side-effect-free treatments for diabetes has always been difficult. Bacterial resistance is recognized as a significant medical concern, highlighting the need to identify new compounds that could serve as potential starting points for addressing or managing infectious diseases. The study focused on the phytochemical extraction of Cirsium verutum (D. Don) Spreng, evaluating its bioactivity and identifying potential molecules through molecular docking that could act as starting compounds for creating alternative drugs to address specific health issues. The aqueous extract demonstrated superior performance, displaying the highest phenolic content and exhibiting notable inhibitory effects on the alpha-glucosidase enzyme (31.39±0.02 mg GAE/gm and 70.46% inhibition with an IC50 value of 37.37±1.46 µg/mL, respectively). The free radical scavenging activity using DPPH indicated the maximum activity in the hexane extracts an IC50 of 442.17±0.42 µg/mL. The extracts of C. verutum demonstrated minimum inhibitory concentration (MIC) values ranging from 0.78 to 12.5 mg/mL and minimum bactericidal concentration (MBC) values ranging from 3.12 to 25 mg/mL in the antibacterial assay. The fully characterized compounds from C. verutum were searched from various papers, followed by their molecular docking. In the molecular docking study, it was discovered that among the seven top candidates, pectolinarin (01) was identified as the most promising candidate, exhibiting a docking score of -11.076 kcal/mol against intestinal alpha-glucosidase. This integrated study approach will aid in the discovery of new antibiotics and the management of diabetes.

Bioactivity antibacterial alpha-glucosidase antioxidant molecular docking diabetes management

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.